Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03480880
Other study ID # NIMHANS/DO/103rd IEC/2016
Secondary ID
Status Completed
Phase Phase 4
First received March 21, 2018
Last updated March 21, 2018
Start date October 1, 2016
Est. completion date June 15, 2017

Study information

Verified date March 2018
Source National Institute of Mental Health and Neuro Sciences, India
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was conducted in two parts:

1. This first part was designed to determine thiopentone dose requirement for induction of anaesthesia with and without the use of Bispectral Index monitoring - Participant and Care Provider in appropriate study arm blinded.

2. As a secondary outcome, Bispectral index monitoring was used to observe changes in neuronal function in intraoperative period as well as haemodynamic changes intraoperatively - Participant and Care Provider blinded.


Description:

Surgery for traumatic brain injury is an anaesthetic challenge fraught with complications such as brain bulge, excessive bleeding, hypotension etc. As yet there are no anaesthetic regimen guidelines to follow for induction of anaesthesia in neurotrauma surgeries. Although the functional effect of anaesthetic agents on neuronal tissue is known quite well, there is lack of studies documenting the effect of these anaesthetic agents on head injured patients. It is also not known whether the requirement of anaesthetic agent in the same as a non head injured patient. This study was designed to assess the requirement of anaesthetic thiopentone in head injured patients and compare the anaesthetic usage with and without Bispectral index (BIS) monitoring. We also observed the real time change in neuronal function using Bispectral Index monitoring after craniotomy, i.e. effectively decompression and release of intracranial pressure intraoperatively.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date June 15, 2017
Est. primary completion date May 30, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Head injury patients coming for surgery

Exclusion Criteria:

- Hypotension/Arrythmias at time of induction

- Extra Dural Hemorrhage

- Extracranial injuries

- Scalp lacerations

- History of Seizures

- No consent

Study Design


Intervention

Device:
Bispectral Index
Thiopentone was administered in 50 mg boluses during induction of anaesthesia, until reduction of Bispectral Index value to less than 50, and total dose of thiopentone recorded.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
National Institute of Mental Health and Neuro Sciences, India

Outcome

Type Measure Description Time frame Safety issue
Primary Thiopentone requirement Difference of thiopentone requirement with and without use of Bispectral Index guidance during induction of anaesthesia in traumatic brain injury patients. Beginning of anaesthetic induction till End of anaesthetic induction
Secondary Intraoperative Bispectral Index changes Observation of Bispectral Index changes during craniotomy and decompression. Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.
Secondary Intraoperative Systolic blood pressure changes Observation of Systolic blood pressure changes during craniotomy and decompression. Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.
Secondary Intraoperative Mean blood pressure changes Observation of Mean blood pressure changes during craniotomy and decompression. Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.
Secondary Intraoperative heart rate changes Observation of heart rate changes during craniotomy and decompression. Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.
See also
  Status Clinical Trial Phase
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT05503316 - The Roll of Balance Confidence in Gait Rehabilitation in Persons With a Lesion of the Central Nervous System N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Terminated NCT03698747 - Myelin Imaging in Concussed High School Football Players
Recruiting NCT05130658 - Study to Improve Ambulation in Individuals With TBI Using Virtual Reality -Based Treadmill Training N/A
Recruiting NCT04560946 - Personalized, Augmented Cognitive Training (PACT) for Service Members and Veterans With a History of TBI N/A
Completed NCT05160194 - Gaining Real-Life Skills Over the Web N/A
Recruiting NCT02059941 - Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring Guidelines N/A
Recruiting NCT03940443 - Differences in Mortality and Morbidity in Patients Suffering a Time-critical Condition Between GEMS and HEMS
Recruiting NCT03937947 - Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
Completed NCT04465019 - Exoskeleton Rehabilitation on TBI
Recruiting NCT04530955 - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS) N/A
Recruiting NCT03899532 - Remote Ischemic Conditioning in Traumatic Brain Injury N/A
Suspended NCT04244058 - Changes in Glutamatergic Neurotransmission of Severe TBI Patients Early Phase 1
Completed NCT03307070 - Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury N/A
Recruiting NCT04274777 - The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
Withdrawn NCT05062148 - Fundamental and Applied Concussion Recovery Modality Research and Development: Applications for the Enhanced Recovery N/A
Withdrawn NCT04199130 - Cognitive Rehabilitation and Brain Activity of Attention-Control Impairment in TBI N/A
Withdrawn NCT03626727 - Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia Early Phase 1